Oncology real-world data and AI company (ex-CancerLinQ data partner), supplying pharma and FDA-facing studies.
ConcertAI, based in Cambridge, Massachusetts, is an oncology real-world data and AI company, formerly the data partner for ASCO's CancerLinQ, supplying pharmaceutical companies and FDA-facing studies. Its offerings include curated electronic health record datasets, digital trial solutions and generative AI clinical tools, with partnerships with NVIDIA and ASCO. OnCo links it to oncology EHR and real-world data platforms. Whether curated real-world datasets reach the quality regulators need for approval decisions, rather than only for market analytics, is the open question for the sector. The real-world data platform page carries the wider picture.
Shares Oncology EHR and real-world data platforms and the tag supporting.
Shares Oncology EHR and real-world data platforms and the tag supporting.
Shares Oncology EHR and real-world data platforms and the tag supporting.
Shares Oncology EHR and real-world data platforms and the tag supporting.
Shares Oncology EHR and real-world data platforms and the tag supporting.
Shares Oncology EHR and real-world data platforms and the tag supporting.
Shares Oncology EHR and real-world data platforms and the tag supporting.
Shares Oncology EHR and real-world data platforms and the tag supporting.
Commercial and regulated products that this organisation sells. Each card says what is behind it: a regulator's database, the literature, a public body's list, or only the company's own words. Listing is not endorsement, and a clearance is a regulatory fact, not a clinical one.
Oncology real-world data and trial acceleration software, sold to sponsors and to the practices whose data it curates.